Bendamustine Hydrochloride for the Treatment of Relapsed or Refractory Acute Leukemia

- Leukemia
- Completed

Study Title: Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Teva Identifier: C18083/2046 | 2010-020768-40

ClinicalTrials.gov Identifier: NCT01088984

Study Status: Completed

Trial Condition(s): Leukemia

Interventions: Drug: Bendamustine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 1 Year to 20 Years

Trial Duration: 08/01/2010 - 08/01/2011

Phase: Phase 1/2

Study Type

Interventional